These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25502430)

  • 21. Screening for gynaecologic cancers in genetically predisposed women.
    Dreyer G
    Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):267-82. PubMed ID: 22361688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
    Michelsen TM; Dørum A; Dahl AA
    Gynecol Oncol; 2009 Apr; 113(1):128-33. PubMed ID: 19178933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential adverse impact of ovariectomy on physical and psychological function of younger women with breast cancer.
    Sayakhot P; Vincent A; Deeks A; Teede H
    Menopause; 2011 Jul; 18(7):786-93. PubMed ID: 21407138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent advances in patient-related outcome in gynaecological cancer].
    Brachet PE; Joly F
    Bull Cancer; 2014; 101(7-8):756-9. PubMed ID: 25025654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study.
    Michelsen TM; Pripp AH; Tonstad S; Tropé CG; Dørum A
    Eur J Cancer; 2009 Jan; 45(1):82-9. PubMed ID: 19008092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.
    Singh K; Lester J; Karlan B; Bresee C; Geva T; Gordon O
    Am J Obstet Gynecol; 2013 Apr; 208(4):329.e1-6. PubMed ID: 23333547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: surgical outcomes and learning curve analysis.
    Escobar PF; Starks DC; Fader AN; Barber M; Rojas-Espalliat L
    Gynecol Oncol; 2010 Oct; 119(1):43-7. PubMed ID: 20579712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.
    Ackermann S; Lux MP; Fasching PA; Strissl P; Renner SP; Poehls U; Bender HG; Beckmann MW
    Eur J Cancer Prev; 2006 Dec; 15(6):474-9. PubMed ID: 17106324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic counselling and prophylactic surgery in women from families with hereditary breast or ovarian cancer.
    Lobb E; Meiser B
    Lancet; 2004 Jun; 363(9424):1841-2. PubMed ID: 15183619
    [No Abstract]   [Full Text] [Related]  

  • 32. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
    Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
    Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: patients' and professionals' perspectives.
    Arts-de Jong M; Harmsen MG; Hoogerbrugge N; Massuger LF; Hermens RP; de Hullu JA
    Gynecol Oncol; 2015 Feb; 136(2):305-10. PubMed ID: 25560807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recommendation for prophylactic surgery for decreasing the risk of gynaecological cancer in women with hereditary risk].
    Zikán M; Kalábová R
    Klin Onkol; 2009; 22 Suppl():S58-9. PubMed ID: 19764400
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening and prevention of hereditary gynecologic cancers.
    Kehoe SM; Kauff ND
    Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing premature menopause and sexual dysfunction.
    Zhou ES; Falk SJ; Bober SL
    Curr Opin Support Palliat Care; 2015 Sep; 9(3):294-300. PubMed ID: 26155020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.
    Kurian AW; Kingham KE; Ford JM
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):23-33. PubMed ID: 25502425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers.
    Kenkhuis MJ; de Bock GH; Elferink PO; Arts HJ; Oosterwijk JC; Jansen L; Mourits MJ
    Maturitas; 2010 Jul; 66(3):310-4. PubMed ID: 20409655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
    Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.